-
It’s official: Meet 4 of the country’s most impressive healthcare startups
A quartet of companies on Wednesday were selected among the 44 companies that presented at MedCity INVEST, MedCity News’ healthcare investing conference.
-
Trayt Health Seeks to Increase Access to Diagnoses and Treatments
CEO Malekeh Amini explains how Trayt Health can bridge the gap for patients seeking neurological care.
-
Morning Read: Get ready to hear a lot about Obamacare 2.0
Also, read about Sequenom’s very important patent fight, a petition for a unique patient ID, and a gentle critique on the Cancer Moonshot.
-
Morning Read: Affymetrix rejects the latest takeover bid meant to derail Thermo Fisher’s offer
Also, the latest hospital cyber attack (a ransomware attack), Zika gets political, a poll on the best kind of HIMSS keynotes, and the Valeant obituaries are rolling in.
-
Morning Read: I know what YOU think of the Express Scripts drug report. But what will the candidates think?
Also, Oscar grabs a Google VP as its CTO, new telemedicine reimbursements and a new policy concept: a $3 billion federal prize for AIDS breakthroughs.
-
Morning Read: Healthcare’s integration into SXSW (2016 edition) is underway
Also, a preview of Valeant’s “watershed” moment, do-it-yourself CRISPR and health insurance experiments that are gaining traction.
-
Morning Read: More bad Theranos news, will family caregivers get their own tax credit?
Also, previews of the CRISPR patent fight and Toshiba medical auction happening this week.
-
Morning Read: Why Nancy Reagan mattered to medical innovation
Also, HIMSS keynote strategy mocked, ACOs continues to be pummeled, and a new European initiative to speed up approval of innovative drugs.
-
HIMSS Day 5 Buzz: It’s all over – and now the work begins
A simple question (followed by a shameless plug): What will we see from HIMSS culminate […]
-
Improving Communication Between Patients and Providers
Sarah Shillington, Chief Customer Officer notes how Artera’s omnichannel platform works.
-
Morning Read: Digital health investing in February, Obamacare hits an important milestone early
Also, more details on the Trump healthcare plan and a ridiculous wellness incentive.
-
MedHeads: Looking back at what was (and wasn’t) said at HIMSS16
Neil Versel and guests break down the week of HIMSS16.
-
#HIMSS16 Day 4 Buzz: Let’s rank the big issues discussed at HIMSS
Also, getting real on HIMSS16 turnout, a hard look at medical scribes and Mitt Romney makes an appearance.
-
Morning Read: Let’s start paying attention to Donald Trump’s healthcare plans
Also, Google gets into the fight for Zika, a new cancer startup using “PARP” inhibitors, and New York claims some insurance companies are rationing care around Hep C drugs.
-
#HIMSS16 Day 3 Buzz: Is there a Donald Trump effect with interoperability policy?
Either way, it’s put up or shut up time with everything that comes after HIMSS.
-
#HIMSS16 Day 2 buzz: It starts with interoperability (will it get serious about security?)
Also, HIMSS shows the JP Morgan crowd how its done, HISTalkapalooza highlights and more updates from the show floor.